» Articles » PMID: 35422493

O-GlcNAcylation and Stablization of SIRT7 Promote Pancreatic Cancer Progression by Blocking the SIRT7-REGγ Interaction

Overview
Specialty Cell Biology
Date 2022 Apr 15
PMID 35422493
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers and its dismal prognosis indicates the urgent need to elucidate the potential oncogenic mechanisms. SIRT7 is a classic NAD-dependent deacetylase that stabilizes the transformed state of cancer cells. However, its functional roles in PDAC are still unclear. Here, we found that SIRT7 expression is upregulated and predicts poor prognosis in PDAC. Then we screened the new interacting proteins of SIRT7 by mass spectrometry and the results showed that SIRT7 can interact with O-GlcNAc transferase (OGT). O-GlcNAcylation stabilizes the SIRT7 protein by inhibiting its interaction with REGγ to prevent degradation, and hyper-O-GlcNAcylation in pancreatic cancer cells leads to hypoacetylation of H3K18 via SIRT7, which promotes transcriptional repression of several tumour suppressor genes. In addition, SIRT7 O-GlcNAcylation at the serine 136 residue (S136) is required to maintain its protein stability and deacetylation ability. In vivo and in vitro experiments showed that blocking SIRT7 O-GlcNAcylation at S136 attenuates tumour progression. Collectively, we demonstrate that O-GlcNAcylation is an important post-translational modification of SIRT7 in pancreatic cancer cells, and elucidating this mechanism of SIRT7 is expected to pave the way for the development of novel therapeutic methods in the future.

Citing Articles

Starvation-induced HBP metabolic reprogramming and STAM2 O-GlcNAcylation facilitate bladder cancer metastasis.

Feng Z, Mei Y, Chen H, Li L, Jin T, Li X Sci Rep. 2025; 15(1):8480.

PMID: 40075080 PMC: 11903858. DOI: 10.1038/s41598-025-92579-4.


Nuclear localization of BRCA1-associated protein 1 is important in suppressing hepatocellular carcinoma metastasis via CTCF and NRF1/OGT axis.

Xie X, Tsui Y, Zhang V, Yu T, Husain A, Chiu Y Cell Death Dis. 2025; 16(1):123.

PMID: 39984455 PMC: 11845619. DOI: 10.1038/s41419-025-07451-0.


PLK3 weakens antioxidant defense and inhibits proliferation of porcine Leydig cells under oxidative stress.

Chen C, He J, Huang W, Xu D, Li Z, Yang A Sci Rep. 2025; 15(1):2612.

PMID: 39837970 PMC: 11751325. DOI: 10.1038/s41598-025-86867-2.


Targeting protein modification: a new direction for immunotherapy of pancreatic cancer.

Ge X, Zhang K, Zhu J, Chen Y, Wang Z, Wang P Int J Biol Sci. 2025; 21(1):63-74.

PMID: 39744438 PMC: 11667816. DOI: 10.7150/ijbs.101861.


Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications.

Chouhan S, Kumar A, Muhammad N, Usmani D, Khan T Cancers (Basel). 2024; 16(23).

PMID: 39682281 PMC: 11640239. DOI: 10.3390/cancers16234095.


References
1.
Barber M, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Moqtaderi Z . SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature. 2012; 487(7405):114-8. PMC: 3412143. DOI: 10.1038/nature11043. View

2.
Torphy R, Fujiwara Y, Schulick R . Pancreatic cancer treatment: better, but a long way to go. Surg Today. 2020; 50(10):1117-1125. PMC: 7837389. DOI: 10.1007/s00595-020-02028-0. View

3.
Jiang L, Xiong J, Zhan J, Yuan F, Tang M, Zhang C . Ubiquitin-specific peptidase 7 (USP7)-mediated deubiquitination of the histone deacetylase SIRT7 regulates gluconeogenesis. J Biol Chem. 2017; 292(32):13296-13311. PMC: 5555190. DOI: 10.1074/jbc.M117.780130. View

4.
Lewis B, Hanover J . O-GlcNAc and the epigenetic regulation of gene expression. J Biol Chem. 2014; 289(50):34440-8. PMC: 4263851. DOI: 10.1074/jbc.R114.595439. View

5.
McGlynn L, McCluney S, Jamieson N, Thomson J, MacDonald A, Oien K . SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer Patients. PLoS One. 2015; 10(6):e0131344. PMC: 4487247. DOI: 10.1371/journal.pone.0131344. View